Biblio
2019
Pichler, H., Lawitschka, A., Glogova, E., Willasch, A.M., von Luettichau, I., Lehrnbecher, T., Matthes-Martin, S., Lang, P., Bader, P., Sykora, K.W., et al. (2019).
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.Am J Hematol.
Stanchi, K.Melanie Ca, Queudeville, M., Malaval, C., Feucht, J., Schlegel, P., Dobratz, M., Seitz, C., Müller, I., Lang, P., Handgretinger, R., et al. (2019).
Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.J Cancer Res Clin Oncol.
2016
Teltschik, H.-M., Heinzelmann, F., Gruhn, B., Feuchtinger, T., Schlegel, P., Schumm, M., Kremens, B., Müller, I., Ebinger, M., Schwarze, C.Philipp, et al. (2016).
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.Br J Haematol.
]